PERKINELMER INC (PKI) Stock Price & Overview

NYSE:PKI • US7140461093

Current stock price

115.24 USD
-1.06 (-0.91%)
At close:
115.24 USD
0 (0%)
After Hours:

The current stock price of PKI is 115.24 USD. Today PKI is down by -0.91%. In the past month the price decreased by -15.23%. In the past year, price decreased by -21.46%.

PKI Key Statistics

52-Week Range113.46 - 170
Current PKI stock price positioned within its 52-week range.
1-Month Range114.287 - 136.89
Current PKI stock price positioned within its 1-month range.
Market Cap
14.568B
P/E
14.51
Fwd P/E
22.11
EPS (TTM)
7.94
Dividend Yield
N/A

PKI Stock Performance

Today
-0.91%
1 Week
-9.97%
1 Month
-15.23%
3 Months
-13.64%
Longer-term
6 Months -15.37%
1 Year -21.46%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

PKI Stock Chart

PERKINELMER INC / PKI Daily stock chart

PKI Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to PKI. When comparing the yearly performance of all stocks, PKI is a bad performer in the overall market: 71.97% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

PKI Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to PKI. While PKI seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PKI Earnings

Next Earnings DateJul 31, 2023
Last Earnings DateMay 11, 2023
PeriodQ1 / 2023
EPS Reported$1.01
Revenue Reported
EPS Surprise -5.99%
Revenue Surprise %

PKI Forecast & Estimates

20 analysts have analysed PKI and the average price target is 159.39 USD. This implies a price increase of 38.31% is expected in the next year compared to the current price of 115.24.

For the next year, analysts expect an EPS growth of -34.36% and a revenue growth -31.32% for PKI


Analysts
Analysts73
Price Target159.39 (38.31%)
EPS Next Y-34.36%
Revenue Next Year-31.32%

PKI Groups

Sector & Classification

Index Membership

PKI Financial Highlights

Over the last trailing twelve months PKI reported a non-GAAP Earnings per Share(EPS) of 7.94. The EPS decreased by -30.47% compared to the year before.


Income Statements
Revenue(TTM)4.57B
Net Income(TTM)746.14M
Industry RankSector Rank
PM (TTM) 16.32%
ROA 5.28%
ROE 10.11%
Debt/Equity 0.53
Chartmill High Growth Momentum
EPS Q2Q%-33.59%
Sales Q2Q%-27.89%
EPS 1Y (TTM)-30.47%
Revenue 1Y (TTM)-3.37%

PKI Ownership

Ownership
Inst Owners86.56%
Shares126.41M
Float125.94M
Ins Owners0.81%
Short Float %N/A
Short RatioN/A

About PKI

Company Profile

PKI logo image PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. The company is headquartered in Waltham, Massachusetts and currently employs 16,700 full-time employees. The firm operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides products and services targeted towards the life sciences and applied markets. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the reproductive health, immunodiagnostics and applied genomics markets. Its products and services for Discovery & Analytical Solutions applications include The Opera Phenix Plus high-content screening system, The Operetta CLS high-content analysis system, The MuviCyte live-cell imaging system, and The Signals Image Artist. Its products and services for Diagnostics applications include The DELFIA Xpress screening platform, The Specimen Gate informatics data management solution and The DELFIA Xpress sFlt-1 kit.

Company Info

IPO: 1965-07-06

PERKINELMER INC

940 Winter Street

Waltham MASSACHUSETTS 02451 US

CEO: Prahlad Singh

Employees: 16700

PKI Company Website

Phone: 17816635776.0

PERKINELMER INC / PKI FAQ

What does PERKINELMER INC do?

PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. The company is headquartered in Waltham, Massachusetts and currently employs 16,700 full-time employees. The firm operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides products and services targeted towards the life sciences and applied markets. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the reproductive health, immunodiagnostics and applied genomics markets. Its products and services for Discovery & Analytical Solutions applications include The Opera Phenix Plus high-content screening system, The Operetta CLS high-content analysis system, The MuviCyte live-cell imaging system, and The Signals Image Artist. Its products and services for Diagnostics applications include The DELFIA Xpress screening platform, The Specimen Gate informatics data management solution and The DELFIA Xpress sFlt-1 kit.


What is the stock price of PERKINELMER INC today?

The current stock price of PKI is 115.24 USD. The price decreased by -0.91% in the last trading session.


What is the dividend status of PERKINELMER INC?

PKI does not pay a dividend.


How is the ChartMill rating for PERKINELMER INC?

PKI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


What is the ex-dividend date for PKI stock?

The next ex-dividend date for PERKINELMER INC (PKI) is July 20, 2023.


What is the next earnings date for PKI stock?

PERKINELMER INC (PKI) will report earnings on 2023-07-31, before the market open.


Who owns PERKINELMER INC?

You can find the ownership structure of PERKINELMER INC (PKI) on the Ownership tab.